Vivani Medical, Inc. (VANI) has disclosed a new risk, in the Accounting & Financial Operations category.
Vivani Medical, Inc. presents a significant risk for investors seeking regular income through dividend payouts. The company has made it clear that it does not plan to distribute cash dividends on its common stock in the foreseeable future, as it intends to reinvest earnings to support business growth and expansion. Furthermore, potential debt financing could impose restrictions on dividend payments. This leaves investors with capital appreciation as the sole potential source of gain—a prospect that is speculative and by no means guaranteed.
Overall, Wall Street has a Moderate Buy consensus rating on VANI stock based on 1 Buy.
To learn more about Vivani Medical, Inc.’s risk factors, click here.
